Anorectic Agents PDF
Document Details
Uploaded by CourteousMilwaukee
Tags
Summary
These notes cover anorectic agents, their actions on the hypothalamus, and their various medical uses. The document also describes CNS stimulant effects, B-agonists, and other related topics.
Full Transcript
## Anorectic Agents **Use:** Anorexia, antiobesity **Act on Hypothalamus at satiety centre** - Phentermine - Phenylpropanolamine - Sibutramine - don't use, biz of Cardiac 8/2, risk of abused drug - Fenfluramine - Dexfenfluramine ## NALO **CNS Stimulant Effects:** e.g Amphetamine, Ephedrine...
## Anorectic Agents **Use:** Anorexia, antiobesity **Act on Hypothalamus at satiety centre** - Phentermine - Phenylpropanolamine - Sibutramine - don't use, biz of Cardiac 8/2, risk of abused drug - Fenfluramine - Dexfenfluramine ## NALO **CNS Stimulant Effects:** e.g Amphetamine, Ephedrine - Methylphenidate - DOC ADHD, abused by athletes, - preferred to Modafinil - Ephedrine - abused by athletes - DOC Narcolepsy - CNS Stimulants, fatigue, ↑ cooperative test **Methylphenidate** - Attention Deficit Hyperactive Disorder - to ↑↑ attention CNS, Stimulant (+) - Narcolepsy - Sleep disorder (uncontrollable sleep attacks) - attacks at any situations any when ## B-Agonists **e.g Bronchodilators (B2) Asthma** - Salbutamol likedry - uterine relaxants (tocolytics) (B2) COPD - e.g Ritadrine, Isoxusprines - use to delay labor ## B3-Agonist - e.g mirabegrot **Bladder relaxant** **Use:** Overactive bladder, aulous burnew - Adipose tissue - antiobesity drug (not approved for obesity) ## Imourably Acting S.Mimetis - TCAs - SNRIs - Cocaine - Tyramine - Ephedrine **Sympatholytics** | | directly | indirectly | |---|---|---| | ↓ | | | | VD | | [JMA ax] | | | | | | | # | | | | ↓ | | | | Relieve the wincoutflow obstructs | | | | | | **Miost, Use HTN HE** | | | | |---|---|---| | | Peripheral vascular disease | | | Male Impotence/Erectile dysfunction | | | | | | | | | VD property | | | | | | | | | | | | Relieve Urine Outflow obstructions | | | | | | | | Benign Prostatic Hypertrophy (BPH) Cenlargement of prostate | | **Rise of Constantio or postava H-TH due to wrine Obst.** - **Terazosin** - less risk of hypotension (mayman 1st dose Stat - C) - **Doxazosin** - HTN & fo BPH & Both (Minimal dose to Prevent it at bed time) - **Tamsulosin** - HTN in dyslipidemia (Pts [DO]) - **Si lo dain** - GOPH HE ## 5/e - Hypotension (postural) - Ejaculation failure (sepuls/2) - Retrograde ejection - Floppy eye syndrome (miolris) **Non Selecture** - [2, ß2 both] | | Im Brodrug (Slow) | Rever (Faster & Short) | |---|---|---| | | | | | | Phenoxy tongr benzemine | Phentolamine, Tolosalde | | | | | | | | Phenoxybenzamine (to control BP) | **USE → HTN RX** - Cheese Rith withdrawal y phentolamin (DOC) - Not use PVD * Risk of Hypotension less then 21 | | | | |---|---|---| | | 2,0 | | | 2,0 | THA | | | | TSBP | | | | | | **Elective L-Blockn** | | | | |---|---|---| | | | | | ↓ | | ↓ | | | Pueyosin | Yohimbine/Rocolsaame | ## B Blocker | | Nonselective | Selecttive | |---|---|---| | | | | | | CB+ | Cardio | | | | | | | e.g Propanolol | e.g Atenol | | | | | | | Nadolol | A2 - acebutolol | | | | | | | Sotalol | B2 - Betoxolol | | | | | | | Pindolol | Celi propol | | | | | ## Metoprolol, Ermolal, Nebivol **Adv. of cardioselectivity** - No risk asthmatic pt. & COPD - No risk of suppressios guerncogenesis in (Quart) - Safr in Diabetic pt. - No risk of Coursing dyscipiderria (espagexeris) DMA & dyslipidemic pt - No risk of Coursing uterine obstruction - No risk of glycogenesis in sk. musde → Athletes... **USE of 2-B0** | Cardiac Uses | Non Cardiac Uses | |---|---| | | | | | | | ↓ | | | | | | | | (Heart pts) | | | | | | | | Cardiosecetrine BO MI, angine, HTN | | | | | | | | Heart failure, Arrhythmia | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | VD | | | | | | | | fentotamise | | | | | | | | | | | | deforest | | | | | | | | LA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (miotics) |- | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Glaucoma Ryp | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |